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How body size is determined is a long-standing
question in biology, yet its regulatory mechanisms
remain largely unknown. Here, we find that a
conserved microRNA miR-8 and its target, USH,
regulate body size in Drosophila. miR-8 null flies are
smaller in size and defective in insulin signaling in
fat body that is the fly counterpart of liver and
adipose tissue. Fat body-specific expression and
clonal analyses reveal that miR-8 activates PI3K,
thereby promoting fat cell growth cell-autonomously
and enhancing organismal growth non-cell-autono-
mously. Comparative analyses identify USH and its
human homolog, FOG2, as the targets of fly miR-8
andhumanmiR-200, respectively.USH/FOG2 inhibits
PI3K activity, suppressing cell growth in both flies
and humans. FOG2directly binds to p85a, the regula-
tory subunit of PI3K, and interfereswith the formation
of a PI3K complex. Our study identifies two novel
regulators of insulin signaling, miR-8/miR-200 and
USH/FOG2, and suggests their roles in adolescent
growth, aging, and cancer.
INTRODUCTION
Animal body size is a biological parameter subject to consider-
able stabilizing selection; animals of abnormal size are strongly
selected against as less fit for survival. Thus, the way in which
body size is determinedand regulated is a fundamental biological
question.Recent studies using insectmodel systemshavebegun
to provide some clues by showing that insulin signaling plays
an important part in modulating body growth (Ikeya et al., 2002;
Rulifson et al., 2002). The binding of insulin (insulin-like peptides
in Drosophila) to its receptor (InR) triggers a phosphorylation
cascade involving the insulin receptor substrate (IRS; chico in
Drosophila), phosphoinositide-3 kinase (PI3K), and Akt/PKB
(Edgar, 2006). An active PI3K complex consists of a catalytic1096 Cell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc.subunit (p110; dp110 in Drosophila) and a regulatory subunit
(p85a; dp60 in Drosophila). Phosphorylated Akt (p-Akt) phos-
phorylates many proteins—including forkhead box O tran-
scription factor (FOXO) —which are involved in cell death, cell
proliferation, metabolism, and life span control (Arden, 2008).
Once activated, the kinase cascade enhances cell growth and
proliferation.
Organismal growth is achieved not only by cell-autonomous
regulation but also by non-cell-autonomous control through
circulating growth hormones (Baker et al., 1993; Edgar, 2006).
Recent studies in insects indicate that several endocrine organs,
such as the prothoracic gland and fat body, govern organismal
growth by coordinating developmental and nutritional conditions
(Caldwell et al., 2005; Colombani et al., 2005; Colombani et al.,
2003; Mirth et al., 2005). However, detailed mechanisms of
how body size is determined and modulated remain largely
unknown.
microRNAs (miRNAs) are noncodingRNAsof22nt that act as
posttranscriptional repressors by base-pairing to the 30 untrans-
lated region (UTR) of their cognate mRNAs (Bartel, 2009). The
physiological functions of individual miRNAs remain largely
unknown. Studies of miRNA function rely heavily on computa-
tional algorithms that predict target genes (John et al., 2004;
Kim et al., 2006; Kiriakidou et al., 2004; Krek et al., 2005; Lewis
et al., 2005; Stark et al., 2003). In spite of their utility, however,
these target prediction programs generate many false-positive
results, because regulation in vivo depends on target message
availability and complementary sequence accessibility. To over-
come the difficulties in identifying real targets, various experi-
mental approaches have been developed, including micro-
arrays, proteomic analyses, and biochemical purification of the
miRNA-mRNA complex (Bartel, 2009). Genetic approaches
using model organisms can also be useful tools for studying
the biological roles ofmiRNAs at both the organismal andmolec-
ular levels (Smibert and Lai, 2008). Despite these advances,
however, it is still a daunting task to understand the biological
function of a given miRNA and to identify its physiologically rele-
vant targets.
Here, we find using Drosophila as a model system that
conserved miRNA miR-8 positively regulates body size by
targeting a fly gene called u-shaped (ush) in fat body cells. We
further discover that this function ofmiR-8 andUSH is conserved
inmammals and that the human homolog of USH, FOG2, acts by
directly binding to the regulatory subunit of PI3K.
RESULTS
Small Body Phenotype of themir-8Mutant
In a screen for miRNAs that modulate cell proliferation, we
observed that human miR-200 miRNAs (miR-200a, miR-200b,
miR-200c, miR-141, and miR-429) promote cell growth when
transfected into several human cell lines (Park et al., 2009)
Figure 1. Growth Defect of mir-8 Mutant
(A) Both male and female miR-8 null flies are
smaller than their wild-type counterparts.
(B) Average weight of wild-type (male, n = 65;
female, n = 70) and miR-8 null (male, n = 60;
female, n = 40) flies.
(C) Left: miR-8 null larvae show retarded growth
phenotype. The larval photograph was taken
100 hr AEL (after egg laying). Right: miR-8 null
larvae pupariate at normal time points (w1118, n =
290; mir-8D2, n = 104) and are slightly delayed in
adult emergence (w1118, n = 248; mir-8D2, n = 70).
(D) Left: miR-8 null flies have reduced wing size.
Right: miR-8 null flies have reduced wing cell
number with no significant change in cell size
(w1118, n = 10; mir-8D2, n = 8).
(E) Reduced level of phospho-Akt (p-Akt) in miR-8
null flies. Measurements were made in triplicate.
(F) Increased level of a FOXO target gene (4EBP) in
miR-8 null larvae as determined by qRT-PCR. *p <
2.93 1010; #p < 3.93 104, compared with wild-
type. Error bars denote the standard error of the
mean (SEM).
(see Figure S1 available online). Members
of the miR-200 family are upregulated in
certain cancers, including ovarian can-
cer, consistent with our observation of
the proliferation promoting effects (Iorio
et al., 2007; Nam et al., 2008). Because
the miR-200 family is highly conserved
in bilaterian animals, with miR-8 being
the sole homolog in Drosophila mela-
nogaster, we used D. melanogaster in
order to uncover the biological function
of the miR-200 family.
We first analyzed the phenotype of the
miR-8 null fly, mir-8D2 (a generous gift
from Steve Cohen) (Karres et al., 2007).
It was previously shown that mir-8 muta-
tion results in increased apoptosis in the
brain and frequent occurrence of mal-
formed legs and wings (in about one-third
of the mutants) (Karres et al., 2007). Inter-
estingly, in addition to these phenotypes,
we found that miR-8 null flies are signi-
ficantly smaller in size (Figure 1A) andmass (Figure 1B) than their
wild-type counterparts.
The determination of the final body size in insects during the
larval stage is analogous to that which occurs during the human
juvenile period (Edgar, 2006; Mirth and Riddiford, 2007). It is
generally known that reduced body size in insects is caused by
either slow larval growth, precocious early pupariation that
shortens the larval growth period, or both (Colombani et al.,
2003; Edgar, 2006; Mirth and Riddiford, 2007). We observed
that, at 100 hr after egg laying (AEL), miR-8 null larvae exhibit
a significantly smaller body volume than do wild-type larvae
(Figure 1C, left). The onset of pupariation in miR-8 null flies wasCell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc. 1097
not significantly different from that in wild-type flies (Figure 1C,
upper right), and adult emergence was slightly delayed (12 hr)
(Figure 1C, lower right). Thus, the smaller body size of miR-8 null
flies is likely to be caused by slower growth during the larval
period rather than by precocious pupariation. Insufficient food
intake has been reported to accompany either precocious or
delayed pupariation, depending on the onset of reduced feeding
(Layalle et al., 2008; Mirth et al., 2005). However, the levels of
Drosophila insulin-like peptides (Dilps), which are known to be
reduced in starvation conditions (Colombani et al., 2003; Ikeya
et al., 2002), were not downregulated in miR-8 null larvae (data
not shown). Given the unaffected onset time of pupariation
(Figure 1C) and the levels of Dilps in this animal, the small body
size of miR-8 null flies is unlikely due to reduced feeding.
Next, we asked whether the small body phenotype was
caused by a reduction in cell size, cell number, or both. We
measured wing cell size and number and found that cell number
was reduced in the wing in miR-8 null flies, whereas cell size was
not significantly different from that of wild-type (Figure 1D). Thus,
assuming that similar regulation takes place in other body parts,
the reduced growth in the peripheral tissues of the miR-8 null
flies may be ascribed to decreased cell number rather than
reduced cell size.
To understand why miR-8 null animals grow slowly, we exam-
ined the activities of the proteins involved in insulin signaling in
the miR-8 null flies. We first determined the level of activated
Akt by Western blotting using a p-Akt-specific antibody (Fig-
ure 1E). The p-Akt level was reduced in themutant flies, suggest-
ing that Akt signaling is impaired in the absence of miR-8
(Figure 1E). Activated p-Akt is known to inactivate FOXO via
phosphorylation. Phosphorylation prevents nuclear localization
of FOXO, which, in turn, results in the reduction of transcription
of FOXO target genes. Consistent with the reduced level of p-
Akt, the FOXO target gene, 4EBP, was increased in mir-8 mutant
larvae (Figure 1F), indicating that insulin signaling is indeed
significantly reduced in the miR-8 null animal.
Fat Body-Specific Expression of miR-8 Rescues
the Small Body Phenotype
We examined the spatial expression pattern of miR-8 in larvae
using a mir-8 enhancer trap GAL4 line (hereafter referred to as
mir-8 gal4), which, when combined with UAS-GFP, expresses
GFP under the control of the mir-8 enhancer (Karres et al.,
2007). In addition to the signals in the brain, wing discs, and leg
discs that were previously observed by Cohen and colleagues
(Karres et al., 2007), we noticed strong signals in the fat body
(Figure 2A and data not shown). We also determined the level
of miR-8 by Northern blotting using total RNA prepared from
different larval organs, which showed that miR-8 is indeed highly
abundant in the fat body (Figure 2B).
Recent studies suggested that Drosophila fat body may be an
important organ in the control of energy metabolism and growth
(Colombani et al., 2003, 2005; Edgar, 2006; Leopold and Perri-
mon, 2007). Therefore, we reasoned that if miR-8 in the larval
fat body is critical for body size control, exclusive expression
of miR-8 in the fat body alone should alleviate the whole body
size defect observed in the mir-8 mutants. To test this idea, we
generated transgenic flies to specifically reintroduce miR-8 into1098 Cell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc.the fat bodies of mir-8 mutant larvae using a fat body–specific
GAL4 driver, Cg gal4 (CgG4) (Takata et al., 2004). Remarkably,
miR-8 expression in the fat body alone rescued the phenotype
to near wild-type levels in both body weight (Figure 2C, left)
and body size (data not shown), suggesting that miR-8 in the
fat body is important for systemic body growth. Another inter-
esting observation was that the miRNAs from the human
miR-200c cluster, which includes miR-200c and miR-141, could
also yield a comparable rescue effect (Figure 2C). Human
miR-200 family miRNAs, which are located in two chromosomal
clusters, have extensive homology to miR-8 (Figure 3A). The fact
that miRNAs of the humanmiR-200c cluster effectively compen-
sate for the loss of miR-8 suggests that these human miRNAs
can be processed by the Drosophila miRNA processing
machinery and that they share a conserved biological function.
Because CgG4 is expressed in the anterior lymph gland as
well as in the fat body (Asha et al., 2003), we used an additional
GAL4 driver, ppl gal4 (pplG4), that is active mainly in the fat body
and slightly in the salivary gland (Zinke et al., 1999). Similar
rescue effects were observed with pplG4, in support of the fat
body–specific function of miR-8 (Figure 2C, right).
As mentioned above, miR-8 is also expressed in the central
nervous system and prevents neurodegeneration (Karres et al.,
2007). To examine whether miR-8 in neuronal cells participates
in the regulation of organismal growth possibly by regulating
feeding behavior indirectly, miR-8 was specifically expressed
in neuronal cells by using elav gal4 (elavG4) in miR-8 null animals.
This genetic manipulation did not alleviate the dwarf phenotype
of miR-8 null flies, indicating that the function of miR-8 in the fat
body is spatiotemporally distinct from that in neuronal tissues
(Figure 2D).
USH Is a Critical Target of miR-8 in the Regulation
of Body Growth
To further understand the molecular function of miR-8, we set
out to identify miR-8 target genes responsible for body size
control. Because miR-8 is a highly conserved miRNA and
because the human homologs promote cell proliferation in
human cells (Figure S1), we assumed that the targets involved
in the cell proliferation phenotype may be conserved throughout
evolution. To discover such conserved targets, we first listed
the candidate target genes of both fly miR-8 and human miR-
200 miRNAs using five different target prediction programs
(Figure 3B): miRanda (John et al., 2004), miTarget (Kim et al.,
2006), microT (Kiriakidou et al., 2004), PicTar (Krek et al.,
2005), and TargetScan (Lewis et al., 2005). The two groups of
putative targets, one from flies and the other from humans,
were then compared with each other to identify homologous
gene pairs. The Drosophila gene u-shaped (ush) and its human
homolog Friend of GATA 2 (FOG2, also known as ZFPM2)
were the most frequently predicted gene pair conserved in both
species. From the target candidate list, we selected 15 genes,
including ush/FOG2, that are known as tumor suppressors or
negative regulators of cell proliferation in at least one species
(Table S1). We validated these target genes with luciferase
reporter plasmids. Briefly, we inserted each target’s 30 UTR,
which contains the miRNA target sites, downstream of a lucif-
erase gene. The reporter activities were measured following
Figure 2. miR-8 in Fat Body Regulates Body Growth
(A) Expression of miR-8 in the larval fat body (denoted by ‘‘F’’), brain (denoted by ‘‘B’’), and cuticle is visualized using mir-8 gal4/UAS-GFP.
(B) miR-8 is highly expressed in the larval fat body. Larval organs were separated and analyzed by Northern blot. Synthetic miR-8 RNA (2 fmole) was included as
a control.
(C) Expression of miR-8 or human miR-200c cluster in the fat body of miR-8 null larvae rescues the small body phenotype. Two fat body–specific GAL4 drivers
(Cg gal4 and ppl gal4) were used (left and right histograms, respectively). n > 45male flies were used for each genotype. *p < 33 1010, comparedwith GAL4-only
control. ##p < 1 3 106; #p < 0.0043, compared with miR-8 null mutant having only the GAL4 transgene.
(D) Expression of miR-8 in neuronal cells did not rescue the small body phenotype of the miR-8 null animal. A neuronal specific GAL4 driver (elav gal4) was used,
and n > 30 male flies were measured for each genotype.cotransfection of miRNAs and the reporter plasmids into
Drosophila S2 or human HeLa cells. After extensive reporter
assays, we identified seven gene pairs that respond both to
miR-8 and to miR-200 family miRNAs in fly and human cells,
respectively (Figure 3C). The full data set is provided in Table S1.
To examine which targets among the candidates are physio-
logically relevant to the phenotype observed, we knocked
down the candidate genes in the fat body of miR-8 null flies
and asked whether the knockdown could rescue the small
body phenotype. Using the UAS-RNA interference (RNAi) linesobtained from the Vienna RNAi Library Centre, dsRNAs of five
candidate geneswere expressed in the fat body ofmir-8mutants
using CgG4. Lap1 knockdown was unsuccessful and, thus, did
not rescue the mir-8 mutant phenotype (Figure S2 and data
not shown). Among the RNAi lines tested, the one against ush
rescued the dwarf phenotype most dramatically (Figure 3D,
upper). RNAi of ush in wild-type background did not significantly
increase body weight, ruling out the possibility that the effects
of ush knockdown and mir-8 mutation are additive (Figure 3D,
lower).Cell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc. 1099
Figure 3. miR-8 Targets USH in Fat Body to Regulate Body Growth
(A) Upper: Sequence alignment of Drosophila miR-8 and human miR-200 family miRNAs. Lower: Genomic organization of the human miR-200 clusters.
(B) Schematic describing the bioinformatic procedure we used to identify common targets of miR-8 and miR-200.
(C) Summary of the results of the bioinformatics analyses and 30 UTR reporter assays. Ts, Targetscan; pt, Pictar; mr, Miranda; mt, miTarget; andmc,microT. Eight
gene pairs were validated by reporter assays in bothDrosophila S2 (left) and human HeLa cells (right). The experiments were performed at least in duplicate, and
the average fold change is presented. Levels of repression of 0.8-fold or more are shown in bold. Predicted targets that gave negative results in the 30 UTR
reporter assays are listed in Table S1.
(D) Upper: genetic rescue experiment by knockdown of miR-8 target genes. dsRNA was expressed in the fat body of miR-8 null larvae using the CgGal4, and the
weights of adult male flies were measured (n > 35 for each genotype). Lower: USH knockdown in the fat body of wild-type larvae does not significantly alter the
body weight (n = 35). **p < 2 3 1010 when compared with miR-8 null mutants with the GAL4 drivers alone.
(E) Introduction of heterozygous ush1513 increases adult body weight (n > 50 male flies for each genotype). #p < 4.1 3 106, compared with miR-8 null flies.
(F) The ush mRNA is upregulated in the fat body of miR-8 null larvae. Measurements in triplicate.
(G) Upper: The USH protein level is increased in the fat body of miR-8 null larvae (lane 3). The negative control (lane 2) is the transheterozyote of a hypomorphic
allele (ush1513) and an amorphic allele (ushvx22). Lower: Quantification of the level of USH in fat body of wild-type and miR-8 null larvae, from three independent
batches. Error bars denote SEM.Because a previous study showed that miR-8 targets atrophin
(atro) to prevent neurodegeneration (Karres et al., 2007), we
tested whether atro is also involved in body size regulation.
Knockdown of atro in the fat body, however, failed to rescue
the small body phenotype of miR-8 null flies (Figure 3D). Thus,
the reported function of miR-8 in the prevention of neurodegen-
eration (Karres et al., 2007) may be separate from its function in
body growth, not only spatially but also at the molecular level. To
exclude possible off-target effects of ush RNAi, we used the
ush1513 hypomorph, which expresses a reduced level of ush as1100 Cell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc.the result of a mutation in the promoter region (Cubadda et al.,
1997). Consistent with the results of the ush RNAi, ush1513
heterozygotes have larger adult bodies than do the control flies
(Figure 3E). This result indicates that USH may indeed suppress
body growth.
Next, we examined whether the level of USH was elevated in
miR-8 null animals. The endogenous ushmRNA level was deter-
mined by qRT-PCR analysis of the RNAs from whole larva or
larval fat body. The ush mRNA is, indeed, significantly upregu-
lated in the fat body of miR-8 null larvae (2.0 fold), suggesting
that miR-8 suppresses ush in the fat body (Figure 3F and
Figure S3A). Upregulation of ush mRNA in whole larval RNA
was less prominent (1.3 fold) (Figure 3F). Thus, ush may be
more strongly suppressed in the fat body than in other body
parts. Notably, USH protein levels are more dramatically
affected than the mRNA levels (Figure 3G and Figure S3B), indi-
cating that miR-8 represses USH production by both mRNA
destabilization and translational inhibition. Furthermore, a point
mutation of the miR-8 target site in the 30 UTR of ush abolished
the suppression of the 30 UTR reporter (Figure S4C), indicating
that the suppression is mediated through the direct binding of
miR-8 to the predicted target site. Putative target sites for miR-
8 are found in all Drosophila species examined, including distant
species such as D. virilis and D. grimshawi (data not shown).
Together, these results demonstrate that ush is an authentic
target of miR-8.
miR-8 and USH Regulate PI3K
Several reports have suggested that insulin signaling in the larval
fat body controls organismal growth in a non-cell-autonomous
manner (Britton et al., 2002; Colombani et al., 2005). In support
of this idea, we observed that suppression of insulin signaling
in the larval fat body yielded smaller flies (Figure S5A) and fewer
cells in the wing (Figure S5B). This phenotype is similar to that of
miR-8 null flies (Figure 1D). To further investigate whether insulin
signaling is indeed defective in the fat body ofmiR-8 null animals,
we used the tGPH reporter, a GFP protein fused to a PH domain
(Britton et al., 2002). Using this technique, the activity of PI3K can
be measured by monitoring the membrane-associated GFP
signal, because PH domains bind to the membrane-anchored
phosphatidylinositol-3,4,5-triphosphate (PIP3) produced by
PI3K. We found that PI3K activity was downregulated in mir-8
mutant fat bodies (Figure 4A, left panel) and that FOXO was
more strongly localized to the nucleus of mutant fat bodies
than the controls (Figure 4A, right panel). Moreover, the level of
p-Akt was significantly reduced in the fat body (Figure S6A,
left), whereas the phosphorylated JNK level did not change
(Figure S6A, right). Thus, insulin signaling is specifically disrup-
ted in the fat bodies of miR-8 null larvae.
To more precisely analyze miR-8’s function in fat cells, flip-out
GAL4 overexpressing clones of miR-8 were generated in the fat
body ofmir-8 heterozygote. In the mosaic fat cells overexpress-
ing miR-8, the tGPH signals was augmented in the membrane,
indicating that miR-8 promotes PI3K activity in a cell-autono-
mous manner (Figure 4B). Cell size also increased with miR-8
overexpression (Figure 4B).
We next generated mitotic null clones to observe the loss of
function phenotype. Cells of the miR-8 null clone were smaller
than the adjacent cells in the twin spot—the cells harboring
wild-type copies of miR-8 (Figure 4C and Figure S7). This
suggests that miR-8 promotes fat cell growth in a cell-autono-
mous manner, as expected if miR-8 enhances insulin signaling
in the fat body. We often found fewer (or no) null clone cells
next to the twin spot cells when the mitotic clones were induced
at embryonic stage or newly hatched larval stage. This suggests
the frequent failure of proliferation and survival of miR-8 null cells
during larval development (Figure 4C and data not shown). It is
noted that we generated null clones of miR-8 in the wing oreye disc but found little growth defect in these organs (Figure S8).
Therefore, the effect of miR-8 on cell growth is dependent on
tissue type, which may be explained by the fact that USH is
present in the fat body but not in wing precursor cells or the
eye disc (Cubadda et al., 1997) (Figure S9).
To determine whether USH negatively regulates insulin
signaling, mosaic clones of fat cells overexpressing USH were
generated. USH-overexpressing cells were smaller in size and
showed significantly lower tGPH signals in the membrane
(Figure 4D and Figure S10) and higher FOXO signals in the
nucleus than did the neighboring wild-type cells (Figure 4E).
We also created mosaic fat cells expressing dsRNA against
ush to observe the knockdown phenotype. The tGPH signal
was significantly enhanced in the mosaic cells depleted of
USH (Figure 4F). In mosaic ush mutant cells, the nuclear FOXO
signals decreased (Figure 4G). Together, our observations indi-
cate that USH inhibits insulin signaling upstream of or in parallel
with PI3K in a cell-autonomous manner.
We further examinedwhether reduced insulin signaling caused
by the absence of miR-8 could be rescued by knockdown of
USH. Excessive insulin signaling is known to reduce the levels
of insulin receptor (Inr) and cytohesin Steppke (step) through
negative feedback by FOXO (Fuss et al., 2006; Puig and Tjian,
2005). These two targets of FOXO were upregulated in the fat
body of miR-8 null larvae, whereas reintroduction of miR-8
dramatically reduced their expression (Figure 4H). Notably, ush
RNAi also restores the mRNA levels of the FOXO target genes
Inr and step in mir-8 mutant fat bodies (Figure 4H). Thus, the
defect of insulin signaling in the fat body of miR-8 null larvae is
at least partially attributable to elevated ush levels.
FOG2, a Target of miR-200, Regulates PI3K in Humans
The ushmRNAhas onepredicted binding site formiR-8,whereas
the mammalian ortholog of ush, FOG2, has at least three pre-
dicted sites for miR-200 family miRNAs (Figures S4A and S4B).
When all the putative sites in the 30 UTR reporter of FOG2 are
mutated (Figure 5A, m123), the reporter became refractory to
the miR-200 family miRNAs. These predicted sites in the 30
UTR of FOG2 are, therefore, responsible for miR-200-mediated
FOG2 regulation. It is noted that miR-200a and miR-141 that
have one nucleotidemismatch in the seed sequence suppressed
the UTR reporter, albeit less effectively than the other members
did (Figure S4D), suggesting that the noncanonical target sites
may also lead to repression (Bartel, 2009; Brennecke et al., 2005).
FOG2 is expressed in the heart, brain, testes, liver, lung, and
skeletal muscle (Holmes et al., 1999; Lu et al., 1999; Svensson
et al., 1999; Tevosian et al., 1999). Despite its relatively broad
expression in adult tissues, little is known about the function of
FOG2 beyond its role in embryonic heart development (Fossett
and Schulz, 2001). The miR-200 miRNAs have also been
reported to be expressed in various adult organs, including pitu-
itary gland, thyroid, pancreatic islet, testes, prostate, ovary,
breast, and liver (Landgraf et al., 2007). We looked for a correla-
tion between the expression of FOG2 protein and miR-200c
cluster miRNAs in human cell lines derived from different organs
(Figure S11). There is generally a negative correlation between
miR-200 miRNAs and FOG2 in a given tissue type, consistent
with a suppressive role for miR-200 in FOG2 regulation.Cell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc. 1101
Figure 4. miR-8 and USH Regulate PI3K-FOXO in Fat Body Cells
(A) Left: Downregulation of PI3K activity is visualized by reduced GFP signal (tGPH) at the plasmamembrane of miR-8 null fat body cells. Right: Enhanced nuclear
localization of FOXO is visualized in miR-8 null fat body cells.
(B) Mosaic fat cells overexpressing miR-8 (marked by the absence of CD2) in mir-8 heterozygote mutant show increased tGPH signals.
(C) Mitotic null clone and its twin spot of miR-8 null cells were generated to show that miR-8 null cells (arrow) growmore slowly and contain less DNA content than
wild-type cells (arrowhead). Fragmentation of the nucleus is observed in some miR-8 null cells.
(D) Fat body cells overexpressing USH (marked by LacZ) show reduced tGPH signals at the plasma membrane. Leaky expression of LacZ not induced by GAL4
is shown in the nucleus of wild-type neighboring cells.
(E) Fat body cells overexpressing USH (marked by GFP) show enhanced nuclear localization of FOXO.1102 Cell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc.
We next sought to confirm the repression of FOG2 bymiR-200
miRNAs. Transfection of miR-200 miRNAs significantly reduced
FOG2 protein levels (Figure 5B) in hepatocellular carcinoma
Huh7 cells that express relatively low but detectable levels of
miR-200 and FOG2 (Figure S11). In addition, the inhibition of
miR-200 miRNAs by 20-O-methyl oligonuclelotides antisense
to miR-200 increased FOG2 protein levels in pancreatic cancer
AsPC1cells that express relatively high levelsofmiR-200miRNAs
(Figure 5C and Figure S11). These data demonstrate that FOG2 is
an authentic target of endogenous miR-200 miRNAs.
Next, we investigated whether human miR-200 miRNAs
have a conserved role in the modulation of insulin signaling,
as in the case of fly miR-8 miRNA. Transfection of miR-200
increases p-Akt levels (Figure 5B), whereas miR-200 inhibitors
reduce p-Akt levels (Figure 5C). Moreover, knockdown of
FOG2 increased p-Akt levels, mimicking the effect of miR-200
(Figure 5D). We also tested the effect of FOG2 on PI3K activity
by immunocomplex kinase assay using an antibody against
p85a (Figure 5E). When Hep3B cells were transfected with a
FOG2-expression plasmid, IGF-1 (Insulin like growth factor–1)
failed to induce PI3K activity, indicating that FOG2 suppresses
PI3K (Figure 5E). Consistent with this result, Akt was not phos-
phorylated in IGF-1–treated cells when FOG2 was ectopically
introduced (Figure 5F). We further analyzed the effect of
miR-200 miRNAs on the downstream transducers of Akt (Fig-
ure S12). Because activated Akt represses FOXO activity, we
used a luciferase reporter plasmid (pFK1tk-luc) containing eight
FOXO-binding sites (Biggs et al., 1999) to determine the level of
FOXO activity in cultured cells. The activity of this FOXO reporter
in Hep3B cells was significantly repressed by transfection of
miR-200 miRNAs and by FOG2 knockdown (Figure S12A).
Furthermore, treating the cells with miR-200 inhibitors elevated
FOXO activity (Figure S12B). Consistently, when FOG2 was
overexpressed, FOXO activity was upregulated (Figure S12C).
In contrast to PI3K pathway components, the level of phos-
phorylated Erk was not significantly impaired (Figure S6B).
In addition, inhibitors of JNK or Mek1/2 did not affect miR-
200–mediated FOXO regulation, whereas PI3K inhibitor abro-
gated this FOXO regulation by miR-200 (Figure S6C). Thus, our
data suggest that miR-200 specifically modulates PI3K-Akt-
FOXO signaling.
Because stimulation of PI3K and Akt is known to facilitate cell
proliferation and antagonize apoptosis (Pollak, 2008), we mea-
sured cellular viability with the MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay in Hep3B cells. Intro-
duction of miR-200 miRNAs increased cell viability (Figure S1B),
whereas miRNA inhibitors produced the opposite effect
(Figure S1C).
To investigate the action mechanism of FOG2, we performed
Western blotting against p85a, p110, and IRS-1 following
p85a immunoprecipitation (Figure 5G). Notably, when FOG2
was expressed, reduced amounts of p110 and IRS-1 were
coprecipitated with p85a. Thus, FOG2 may act as a negativeregulator of PI3K by interfering with the formation of a IRS-1/
p85a/p110 complex.
FOG2 Directly Binds to p85a to Inhibit PI3K
Although FOG2 is thought to be a nuclear transcriptional coregu-
lator, several studies have reported that FOG2 also localizes to
the cytoplasm (Bielinska et al., 2005; Clugston et al., 2008). To
confirm this finding, we performed subcellular fractionation and
Western blotting. FOG2 was, in fact, observed predominantly
in the cytoplasm rather than in the nucleus in HeLa and PANC1
cells (Figure 6A). Immunostaining also showed cytoplasmic
localization of FOG2 in HepG2 cells (Figure 6B), suggesting a
cytoplasmic role of FOG2.
Given that FOG2 suppresses PI3K and colocalizes with p85a
(Figures 5 and 6), we suspected that FOG2 may interact with
PI3K. Notably, a significant amount of p85a, the regulatory
subunit of PI3K, was coprecipitated with anti-FOG2 antibody
(Figure 6C). Interaction between FOG2 and p85a was also
observed when the FOG2 was ectopically expressed in a
FLAG-tagged form (Figure 6D and Figure S13).
To map the interaction domain of FOG2, several truncated
mutants of FOG2 were generated. The mutants containing
a FLAG-tag in the N termini were coexpressed with V5-tagged
p85a and were analyzed by immunoprecipitation using anti-
FLAG antibody. The results indicate that the middle region of
FOG2 (507–789 aa) mediates the interaction with p85a (Fig-
ure 6D). We then asked whether the middle region is sufficient
to inhibit PI3K activity when it is ectopically expressed in
HepG2 cells (Figure 6E). The middle region suppressed PI3K,
whereas neither the N-terminal part nor the C-terminal part had
a significant effect on PI3K activity (Figure 6E).
To test whether FOG2 binds to p85a directly, the FOG2 protein
was expressed and purified from bacteria and was used in an
in vitro binding assay, along with purified recombinant p85a
protein fused to GST. The recombinant FOG2 protein containing
the middle region of FOG2 (413-789 aa) specifically bound to
recombinant p85a (Figure 6F).
Finally, we asked whether FOG2 can directly inhibit p85a by
performing an in vitro PI3K assay using recombinant FOG2.
Addition of the recombinant FOG2 protein containing the middle
region (FOG2[413-789]) to the immunoprecipitated PI3K com-
plex significantly inhibited the PI3K activity (Figure 6G). This
finding suggests that direct binding of FOG2 to p85a leads to
the inhibition of PI3K activity. Notably, we also found that
Drosophila USH physically interacts with Drosophila p60 (dp60,
the fly ortholog of p85a) when dp60 is coexpressed with USH
in human HEK293T cells (Figure S14). Therefore, the action
mechanism of USH/FOG2 may be conserved across the phyla.
DISCUSSION
Our study reveals two novel regulatory components of insulin
signaling: miR-8/miR-200 and USH/FOG2 (Figure 7). miR-8/200(F) Mosaic fat cells depleted of USH (marked by the absence of CD2 signal) in mir-8 heterozygous mutant show an increase of tGPH signal.
(G) Fat cells homozygous for ushvx22 (marked by the absence of GFP signal), a putative amorphic mutant of ush, show reduced nuclear localization of FOXO.
(H) Expression of miR-8 or dsRNA of ush in the fat body reactivates insulin signaling, as measured by qRT-PCR of Inr and step in the larval fat body. Error bars
denote the SEM.Cell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc. 1103
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Figure 5. FOG2 Is Targeted by miR-200 to Regulate PI3K-Akt
(A) Site-directed mutagenesis of three target sites in the 30 UTR of FOG2. miRNAs with identical seed sequences were pooled in equal amounts, and the mixture
(30 nM in total) was transfected into HeLa cells; miR-141/200a and miR-200b/c/429 (n = 3, mean ± SEM).
(B) miR-200 miRNAs downregulate the FOG2 protein level, resulting in an increase of p-Akt in Huh7 cells. siRNA against GFP (siGFP) was used as a negative
control (n = 3, mean ± SEM).
(C) Inhibitors against miR-200 miRNAs upregulate FOG2 and downregulate p-Akt in AsPC1 cells (n = 3, mean ± SEM).
(D) siRNA against FOG2 (siFog2) increases the p-Akt level in FAO cells (n = 3, mean ± SEM).
(E) Ectopic expression of FOG2 suppresses IGF-1-induced PI3K activity. Hep3B cells were treated with IGF-1 (100 ng/ml) for 20 min (n = 3, mean ± SEM).
(F) Ectopic expression of FOG2 suppresses IGF-1-induced p-Akt. Hep3B cells were treated with IGF-1 (100 ng/ml) for 20 min (n = 3, mean ± SEM).
(G) Ectopic expression of FOG2 disturbs the formation of an active PI3K complex containing p85a, p110, and IRS-1. Quantification from three biological repli-
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Figure 6. FOG2 Directly Binds to p85a to Inhibit PI3K
(A) Cytoplasmic localization of FOG2. The nuclear (‘‘N’’) and cytosolic (‘‘C’’) fractions of HeLa and PANC1 cells were analyzed byWestern blotting with anti-FOG2
antibody. Lamin and tubulin were used as nuclear and cytoplasmic markers, respectively.
(B) Endogenous FOG2 is visualized in HepG2 cell by using anti-FOG2 antibody.
(C) Coimmunoprecipitation of p85a with FOG2. Endogenous FOG2 was immunoprecipitated with anti-FOG2 antibody from total cell extract from PANC1 cells.
Zinc chloride was added, instead of EDTA, to IP buffer, which we found increased the affinity between p85a and FOG2.Western blot analysis was performedwith
anti-p85a and anti-FOG2 antibodies.
(D) Upper left: Schematic representation of full-length (1–1151) and five truncated FOG2 proteins. Red boxes indicate the location of zinc finger motifs. Lower left
and right: Coimmunoprecipitation of p85a with Flag-tagged FOG2 in HepG2 cells. Note that the IP efficiency is lower in this experiment because the IP buffer
contains EDTA, not zinc chloride.
(E) The truncated FOG2 containing the middle region (413–789 aa) inhibits PI3K activity in vivo (n = 3, mean ± SEM).
(F) In vitro binding assay shows direct interaction between recombinant GST-p85a and recombinant His-FOG2[413-789].
(G) Dose-dependent reduction of PI3K activity by recombinant His-FOG2[413–789] (n = 3, mean ± SEM).Cell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc. 1105
negatively regulates USH/FOG2 through direct base-pairing
to the 30 UTR of the ush/FOG2 mRNA. USH/FOG2, in turn,
inhibits the formation of an activePI3Kcomplex via direct interac-
tion with dp60/p85a, the regulatory subunit of PI3K. In fly fat
bodies, miR-8 suppresses ush, which causes cell-autonomous
increase of fat cell growth (see Figure 7 for a model). The roles
of miR-8 and USH are conserved in mammals; miR-200 miRNAs
target FOG2 to upregulate insulin signaling and cell proliferation
in human cells. Given that the PI3K-Akt-FOXO pathway plays
central roles in many developmental processes and that defects
of this pathway have been associated with cancer, diabetes,
neuropathology, and aging (Arden, 2008; Pollak, 2008), further
investigation of the miR-8/200 family and USH/FOG2 may
contribute to the understanding and amelioration of such human
diseases.
Our results support and extend the emerging theory that the
fat body is a central organ coordinating metabolic condition
and global growth of the organism. We propose that miR-8
regulates the growth of peripheral tissues in a non-cell-autono-
mous manner by modulating the secretion of the humoral
factors that are under the control of insulin signaling (Figure 7).
Future investigation is needed to identify the humoral factors
that mediate the communication between the fat body and
other tissues. Because the larval fat body is considered the
Drosophila counterpart of mammalian liver and adipose tissues
(Leopold and Perrimon, 2007), it will be interesting to study
whether miR-200 and FOG2 play a similar role in liver and
adipose tissues to control body growth during the human juve-
nile period.
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Figure 7. Model for the Functions of miR-8/miR-200 and USH/FOG2
In Drosophila, miR-8 posttranscriptionally represses USH, thereby activating
insulin signaling, which results in cell-autonomous growth of fat body cells.
This process also causes nonautonomous organismal growth, likely through
the induction of humoral factors. In human liver cells, miR-200 posttranscrip-
tionally represses FOG2, which directly binds to p85a and blocks the formation
of an active PI3K complex. As such, the repression of FOG2 by miR-200 stim-
ulates insulin signaling and cell proliferation.1106 Cell 139, 1096–1108, December 11, 2009 ª2009 Elsevier Inc.Previous studies suggest that USH/FOG2 may function as
either transcriptional coactivators or corepressors by partnering
with various GATA transcription factors. However, FOG2 is
localized to the cytoplasm in some tissues (Bielinska et al.,
2005; Clugston et al., 2008) (Figure 6A). FOG1, the other human
homolog of Drosophila USH, was also reported to remain in the
cytoplasm of skin stem cells that lack GATA-3 (Kaufman et al.,
2003) and was shown to be sequestered in the cytoplasm by
a cytoplasmic protein TACC3 (Garriga-Canut and Orkin,
2004). USH/FOG2 have been studied mainly in hematopoiesis
and heart development in both flies and mammals (Fossett
and Schulz, 2001; Fossett et al., 2001; Holmes et al., 1999;
Lu et al., 1999; Svensson et al., 1999; Tevosian et al., 1999).
However, it was recently shown that USH suppresses cell prolif-
eration in Drosophila hemocytes (Sorrentino et al., 2007). It is
also noteworthy that FOG2 is frequently downregulated in
human cancers of the thyroid (NCBI GEO accession:
GSE3678), lung (Wachi et al., 2005), and prostate (Nanni
et al., 2006), which suggests a role of FOG2 as a tumor
suppressor. To our knowledge, our study reports for the first
time that FOG2 acts as a negative modulator of the PI3K-Akt
pathway via direct binding to p85a. It remains to be deter-
mined whether the newly discovered molecular function of
USH/FOG2 is related to the previously described phenotypes
of ush/FOG2.
Our study also offers a comprehensive way of discovering the
physiological function of conserved miRNAs. By systematically
mapping the protein homologs of miRNA targets and by vali-
dating them experimentally, we identified seven gene pairs as
conserved targets of the miR-8/200 family. We also used fly
genetics and human cell biology to identify ush/FOG2 as the
target gene that is responsible for one particular phenotype.
Of note, six other genes (Lap1/ERBB2IP, CG8445/BAP1, dbo/
KLHL20, Lar/PTPRD, Ced-12/ELMO2, and CG12333/WDR37)
may also be authentic targets of miR-8/200, although they need
to be further verified by additional methods. These six genes
may function in different organs and/or at different develop-
mental stages. Cohen and colleagues previously reported that
miR-8 prevents neurodegeneration by targeting atro (Karres
et al., 2007). We observe that atro knockdown does not rescue
the small body phenotype of mir-8 mutants (Figure 3D) and that
ush knockdown cannot reverse the wing and leg defects attrib-
uted to atro (data not shown). Thus, a single miRNA may have
several distinct functions in different cell types, likely depending
on the availability of specific targets or downstream effectors.
In a recent study, miR-8 gain of function was shown to affect
the WNT pathway, although this finding was not sufficiently sup-
ported by the phenotype resulting from miR-8 loss of function
(Kennell et al., 2008). The miR-200 family has also been shown
to interfere with epithelial to mesenchymal transitions in humans
(Gregory et al., 2008) to enhance cancer cell colonization in
distant tissues (Dykxhoorn et al., 2009) and to regulate olfactory
neurogenesis and osmotic stress in zebrafish (Choi et al., 2008;
Flynt et al., 2009). It remains to be determined whether these
previously described functions of the miR-8/200 microRNAs
are systemically interconnected in a single organism and how
widely each of these functions is conserved among animals
expressing miR-8/200 microRNAs.
EXPERIMENTAL PROCEDURES
Fly Strains
mir-8D2 mutant was a generous gift from Steve Cohen, and mir-8 gal4
(P{GawB}NP5427) was obtained from the Kyoto Stock Centre. FRT42D
mir-8D2 fly was generated following conventional recombination procedure
and was selected for G418 resistance of FRT. UAS-ush, ush1513, and ushvx22
were generous gifts of Pascal Heitzler, Pat Simpson, and K. VijayRaghavan.
FRT40A ushvx22 was a generous gift from Marc Haenlin. Cg gal4 and ppl gal4
were kindly provided by YoungJoon Kim and M. Pankratz, respectively.
UAS-RNAi lines used in this study were purchased from the Vienna RNAi
Library Centre. ush gal4 (P{GawB}ushMD751), UAS-PI3KDN (P{Dp110D954A}),
Aygal4 UAS-GFP, Aygal4 UAS-LacZ, tGPH, and FRT42D EGUF/hid fly
(BL-5251) stocks were obtained from the Bloomington Drosophila Stock
Center. Act > CD2 > gal4; tGPH was a generous gift from Bruce Edgar.
Measurement of Weight, Size, Pupariation, and Adult Emergence
Flies were grown on standard fly food at 25C. Groups of five animals were
weighed 3–5 days after eclosion. All flies were ice-anesthetized before weight
measurement. To examine the time of pupariation and adult emergence, eggs
were collected for 5 hr, and the number of new pupa or adults were counted
every 12 hr.
Clonal Analysis
Mitotic null clones in larval fat body were generated by heat shock at 39C for
2 hr right after collection of eggs for 9 hr. For inducing the flip-out GAL4 over-
expression clone, embryos and newly hatched larva were heat shocked at
39C for 10 min.
Immunostaining
Mid-third instar larvae (96 hr AEL) were dissected and fixed in 4% formalde-
hyde and blocked as previously described (Lee et al., 2005), except in the
case of tGPH visualization. For tGPH staining, Zamboni’s fixative (4% parafor-
maldehyde and 7.5% saturated picric acid in PBS) was used for tissue fixation.
Antibodies against GFP (1:200, Sigma), LacZ (1:1000, Promega), CD2 (1:200,
Serotec), and FOXO (1:500, a gift from O. Puig) were used. Anti-mouse Alexa
488/594 and anti-rabbit Alexa 488/594 secondary antibodies (1:200, Molec-
ular Probes) were used. To visualize cell membranes, phalloidin-TRITC
(Sigma) was added during secondary antibody incubation. DAPI was used
for DNA staining. The images were obtained with a Zeiss LSM510 confocal
microscope.
Immunoprecipitation and PI3K Assay
Hep3B cell lysates were prepared using lysis buffer (137mMNaCl, 20mMTris-
HCl [pH 7.4], 1 mM CaCl2, 1 mM MgCl2, 0.1 mM sodium orthovanadate, and
1% NP-40), and PI3K was immunoprecipitated with anti-p85a monoclonal
antibody (sc-1637, Santa Cruz). Immunocomplexes were collected on protein
A-Sepharose beads, washed twice with lysis buffer, and washed twice with
wash buffer (0.1 M Tris-HCl [pH 7.4], 5 mM LiCl, and 0.1 mM sodium orthova-
nadate). PI3K activity was assayed by adding 10 mg of sonicated PIP2 (Calbio-
chem) and 1 ml of [g-32P]ATP (500 mCi/ml) in 60 ml of kinase assay buffer (10mM
Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM sodium orthovanadate, and 10 ml of
100 mM MgCl2). The reactions were terminated after 20 min at 37
C by the
addition of 20 ml of 6N HCl. The lipids were extracted with CHCl3:MeOH (1:1)
and were analyzed using scintillation counter. For in vitro PI3K activity assay,
the immunocomplexes were incubated with purified His-tagged FOG2
proteins for 2 hr at 4C.
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